<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>8176119</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">34093290</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">8176119</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.3389/fpsyt.2021.681701</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1</table-label><table-caption>Demographics and clinical data of the patients with schizophrenia, patients with obsessive-compulsive disorder, and healthy controls.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="T1" position="float"><label>Table 1</label><caption><p>Demographics and clinical data of the patients with schizophrenia, patients with obsessive-compulsive disorder, and healthy controls.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Characteristic</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>SCZ</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>OCD</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>HC</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold><italic>F</italic>/χ<sup><bold>2</bold></sup></bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold><italic>P</italic></bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Gender (male/female)</td><td valign="top" align="left" rowspan="1" colspan="1">53/35</td><td valign="top" align="left" rowspan="1" colspan="1">37/21</td><td valign="top" align="left" rowspan="1" colspan="1">34/38</td><td valign="top" align="left" rowspan="1" colspan="1">4.270</td><td valign="top" align="left" rowspan="1" colspan="1">0.118</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age (years)</td><td valign="top" align="left" rowspan="1" colspan="1">25.2 ± 6.4</td><td valign="top" align="left" rowspan="1" colspan="1">27.2 ± 6.6</td><td valign="top" align="left" rowspan="1" colspan="1">24.4 ± 3.4</td><td valign="top" align="left" rowspan="1" colspan="1">3.994</td><td valign="top" align="left" rowspan="1" colspan="1">0.020</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Education (years)</td><td valign="top" align="left" rowspan="1" colspan="1">13.6 ± 2.9</td><td valign="top" align="left" rowspan="1" colspan="1">15.1 ± 2.8</td><td valign="top" align="left" rowspan="1" colspan="1">16.8 ± 2.1</td><td valign="top" align="left" rowspan="1" colspan="1">29.26</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Framewise displacement</td><td valign="top" align="left" rowspan="1" colspan="1">0.068 ± 0.038</td><td valign="top" align="left" rowspan="1" colspan="1">0.066 ± 0.038</td><td valign="top" align="left" rowspan="1" colspan="1">0.058 ± 0.034</td><td valign="top" align="left" rowspan="1" colspan="1">1.428</td><td valign="top" align="left" rowspan="1" colspan="1">0.242</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Onset age (years)</td><td valign="top" align="left" rowspan="1" colspan="1">22.1 ± 6.6</td><td valign="top" align="left" rowspan="1" colspan="1">19.6 ± 5.5</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Disease course (months)</td><td valign="top" align="left" rowspan="1" colspan="1">45.8 ± 52.6</td><td valign="top" align="left" rowspan="1" colspan="1">95.2 ± 66.9</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PANSS total score</td><td valign="top" align="left" rowspan="1" colspan="1">69.26 ± 14.62</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PANSS positive symptoms</td><td valign="top" align="left" rowspan="1" colspan="1">18.90 ± 5.86</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PANSS negative symptoms</td><td valign="top" align="left" rowspan="1" colspan="1">17.02 ± 5.48</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PANSS general psychopathology</td><td valign="top" align="left" rowspan="1" colspan="1">33.34 ± 7.98</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Y-BOCS total score</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">21.46 ± 7.52<xref ref-type="table-fn" rid="TN1"><sup>∧</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Y-BOCS obsessive thinking</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">11.28 ± 3.80<xref ref-type="table-fn" rid="TN1"><sup>∧</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Y-BOCS compulsive behavior</td><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">10.18 ± 4.75<xref ref-type="table-fn" rid="TN1"><sup>∧</sup></xref></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HAMA</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">11.15 ± 6.89<xref ref-type="table-fn" rid="TN2"><sup>†</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HAMD-17</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">7.98 ± 5.22<xref ref-type="table-fn" rid="TN2"><sup>†</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td><td valign="top" align="left" rowspan="1" colspan="1">-</td></tr></tbody></table><table-wrap-foot><p><italic>Data are given as mean ± standard deviation. P-values refer to one-way ANOVA (parametric data) and chi-square test (categorical data)</italic>.</p><p><italic>SCZ, patients with schizophrenia; OCD, patients with obsessive-compulsive disorder; HC, healthy controls; PANSS, Positive and Negative Syndrome Scale; Y-BOCS, Yale–Brown Obsessive-Compulsive Scale; HAMA, Hamilton Anxiety Scale; HAMD-17, 17-item Hamilton Depression Scale; -, not applicable</italic>.</p><fn id="TN1"><label>∧</label><p><italic>N = 50;</italic></p></fn><fn id="TN2"><label>†</label><p><italic>N = 53</italic>.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographics and clinical data of the patients with schizophrenia, patients with obsessive-compulsive disorder, and healthy controls.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left">Characteristic</th><th valign="top" align="left">SCZ</th><th valign="top" align="left">OCD</th><th valign="top" align="left">HC</th><th valign="top" align="left">F/χ2</th><th valign="top" align="left">P</th></tr></thead><tbody><tr><td valign="top" align="left">Gender (male/female)</td><td valign="top" align="left">53/35</td><td valign="top" align="left">37/21</td><td valign="top" align="left">34/38</td><td valign="top" align="left">4.270</td><td valign="top" align="left">0.118</td></tr><tr><td valign="top" align="left">Age (years)</td><td valign="top" align="left">25.2 ± 6.4</td><td valign="top" align="left">27.2 ± 6.6</td><td valign="top" align="left">24.4 ± 3.4</td><td valign="top" align="left">3.994</td><td valign="top" align="left">0.020</td></tr><tr><td valign="top" align="left">Education (years)</td><td valign="top" align="left">13.6 ± 2.9</td><td valign="top" align="left">15.1 ± 2.8</td><td valign="top" align="left">16.8 ± 2.1</td><td valign="top" align="left">29.26</td><td valign="top" align="left">&lt;0.001</td></tr><tr><td valign="top" align="left">Framewise displacement</td><td valign="top" align="left">0.068 ± 0.038</td><td valign="top" align="left">0.066 ± 0.038</td><td valign="top" align="left">0.058 ± 0.034</td><td valign="top" align="left">1.428</td><td valign="top" align="left">0.242</td></tr><tr><td valign="top" align="left">Onset age (years)</td><td valign="top" align="left">22.1 ± 6.6</td><td valign="top" align="left">19.6 ± 5.5</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td></tr><tr><td valign="top" align="left">Disease course (months)</td><td valign="top" align="left">45.8 ± 52.6</td><td valign="top" align="left">95.2 ± 66.9</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td></tr><tr><td valign="top" align="left">PANSS total score</td><td valign="top" align="left">69.26 ± 14.62</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td></tr><tr><td valign="top" align="left">PANSS positive symptoms</td><td valign="top" align="left">18.90 ± 5.86</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td></tr><tr><td valign="top" align="left">PANSS negative symptoms</td><td valign="top" align="left">17.02 ± 5.48</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td></tr><tr><td valign="top" align="left">PANSS general psychopathology</td><td valign="top" align="left">33.34 ± 7.98</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td></tr><tr><td valign="top" align="left">Y-BOCS total score</td><td valign="top" align="left">-</td><td valign="top" align="left">21.46 ± 7.52???</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td></tr><tr><td valign="top" align="left">Y-BOCS obsessive thinking</td><td valign="top" align="left">-</td><td valign="top" align="left">11.28 ± 3.80???</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td></tr><tr><td valign="top" align="left">Y-BOCS compulsive behavior</td><td/><td valign="top" align="left">10.18 ± 4.75???</td><td/><td/><td/></tr><tr><td valign="top" align="left">HAMA</td><td valign="top" align="left">-</td><td valign="top" align="left">11.15 ± 6.89???</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td><td/></tr><tr><td valign="top" align="left">HAMD-17</td><td valign="top" align="left">-</td><td valign="top" align="left">7.98 ± 5.22???</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td><td valign="top" align="left">-</td></tr></tbody></table></div>Data are given as mean ± standard deviation. P-values refer to one-way ANOVA (parametric data) and chi-square test (categorical data).SCZ, patients with schizophrenia; OCD, patients with obsessive-compulsive disorder; HC, healthy controls; PANSS, Positive and Negative Syndrome Scale; Y-BOCS, Yale–Brown Obsessive-Compulsive Scale; HAMA, Hamilton Anxiety Scale; HAMD-17, 17-item Hamilton Depression Scale; -, not applicable.∧N = 50;†N = 53.</transformed-table></extracted-table><extracted-table><table-id>T2</table-id><table-label>Table 2</table-label><table-caption>Results of ALFF analysis of the patients with schizophrenia, patients with obsessive-compulsive disorder, and healthy controls.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="T2" position="float"><label>Table 2</label><caption><p>Results of ALFF analysis of the patients with schizophrenia, patients with obsessive-compulsive disorder, and healthy controls.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Brain region</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Hemisphere</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Cluster size</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>MNI coordinates (x, y, z)</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Peak <italic>F</italic> value</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Voxel-level <italic>P</italic><sub><bold>FWE</bold></sub></bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Hippocampus</td><td valign="top" align="left" rowspan="1" colspan="1">Right</td><td valign="top" align="left" rowspan="1" colspan="1">32</td><td valign="top" align="left" rowspan="1" colspan="1">21, −30, −3</td><td valign="top" align="left" rowspan="1" colspan="1">35.04</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Posterior cingulate cortex</td><td valign="top" align="left" rowspan="1" colspan="1">Left</td><td valign="top" align="left" rowspan="1" colspan="1">47</td><td valign="top" align="left" rowspan="1" colspan="1">−3, −30, 21</td><td valign="top" align="left" rowspan="1" colspan="1">28.88</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Caudate</td><td valign="top" align="left" rowspan="1" colspan="1">Left</td><td valign="top" align="left" rowspan="1" colspan="1">36</td><td valign="top" align="left" rowspan="1" colspan="1">−9, 6, 9</td><td valign="top" align="left" rowspan="1" colspan="1">21.57</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">−12, 15, 9</td><td valign="top" align="left" rowspan="1" colspan="1">20.67</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">−15, 18, −3</td><td valign="top" align="left" rowspan="1" colspan="1">15.93</td><td valign="top" align="left" rowspan="1" colspan="1">0.023</td></tr></tbody></table><table-wrap-foot><p><italic>ALFF, amplitude of low-frequency fluctuations; MNI, Montreal Neurological Institute</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Results of ALFF analysis of the patients with schizophrenia, patients with obsessive-compulsive disorder, and healthy controls.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left">Brain region</th><th valign="top" align="left">Hemisphere</th><th valign="top" align="left">Cluster size</th><th valign="top" align="left">MNI coordinates (x, y, z)</th><th valign="top" align="left">Peak F value</th><th valign="top" align="left">Voxel-level PFWE</th></tr></thead><tbody><tr><td valign="top" align="left">Hippocampus</td><td valign="top" align="left">Right</td><td valign="top" align="left">32</td><td valign="top" align="left">21, −30, −3</td><td valign="top" align="left">35.04</td><td valign="top" align="left">&lt;0.001</td></tr><tr><td valign="top" align="left">Posterior cingulate cortex</td><td valign="top" align="left">Left</td><td valign="top" align="left">47</td><td valign="top" align="left">−3, −30, 21</td><td valign="top" align="left">28.88</td><td valign="top" align="left">&lt;0.001</td></tr><tr><td valign="top" align="left">Caudate</td><td valign="top" align="left">Left</td><td valign="top" align="left">36</td><td valign="top" align="left">−9, 6, 9</td><td valign="top" align="left">21.57</td><td valign="top" align="left">&lt;0.001</td></tr><tr><td/><td/><td/><td valign="top" align="left">−12, 15, 9</td><td valign="top" align="left">20.67</td><td valign="top" align="left">&lt;0.001</td></tr><tr><td/><td/><td/><td valign="top" align="left">−15, 18, −3</td><td valign="top" align="left">15.93</td><td valign="top" align="left">0.023</td></tr></tbody></table></div>ALFF, amplitude of low-frequency fluctuations; MNI, Montreal Neurological Institute.</transformed-table></extracted-table><extracted-table><table-id>T3</table-id><table-label>Table 3</table-label><table-caption>Results of ALFF-based rsFC analysis with the left caudate as the seed in the patients with schizophrenia, patients with obsessive-compulsive disorder, and healthy controls.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="T3" position="float"><label>Table 3</label><caption><p>Results of ALFF-based rsFC analysis with the left caudate as the seed in the patients with schizophrenia, patients with obsessive-compulsive disorder, and healthy controls.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Brain region</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Hemisphere</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Cluster size</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>MNI coordinates (x, y, z)</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Peak <italic>F</italic> value</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Cluster-level <italic>P</italic><sub><bold>FWE</bold></sub></bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Thalamus</td><td valign="top" align="left" rowspan="1" colspan="1">Right</td><td valign="top" align="left" rowspan="1" colspan="1">102</td><td valign="top" align="left" rowspan="1" colspan="1">6, −27, 12</td><td valign="top" align="left" rowspan="1" colspan="1">14.49</td><td valign="top" align="left" rowspan="1" colspan="1">0.003</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Supplementary motor complex</td><td valign="top" align="left" rowspan="1" colspan="1">Right</td><td valign="top" align="left" rowspan="1" colspan="1">107</td><td valign="top" align="left" rowspan="1" colspan="1">27, 15, 54</td><td valign="top" align="left" rowspan="1" colspan="1">12.99</td><td valign="top" align="left" rowspan="1" colspan="1">0.003</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Supplementary motor complex</td><td valign="top" align="left" rowspan="1" colspan="1">Left</td><td valign="top" align="left" rowspan="1" colspan="1">103</td><td valign="top" align="left" rowspan="1" colspan="1">−21, 12, 60</td><td valign="top" align="left" rowspan="1" colspan="1">12.17</td><td valign="top" align="left" rowspan="1" colspan="1">0.003</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cerebellum posterior lobe</td><td valign="top" align="left" rowspan="1" colspan="1">Right</td><td valign="top" align="left" rowspan="1" colspan="1">92</td><td valign="top" align="left" rowspan="1" colspan="1">21, −42, −51</td><td valign="top" align="left" rowspan="1" colspan="1">12.74</td><td valign="top" align="left" rowspan="1" colspan="1">0.006</td></tr></tbody></table><table-wrap-foot><p><italic>ALFF, amplitude of low-frequency fluctuations; rsFC, resting-state functional connectivity; MNI, Montreal Neurological Institute</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Results of ALFF-based rsFC analysis with the left caudate as the seed in the patients with schizophrenia, patients with obsessive-compulsive disorder, and healthy controls.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left">Brain region</th><th valign="top" align="left">Hemisphere</th><th valign="top" align="left">Cluster size</th><th valign="top" align="left">MNI coordinates (x, y, z)</th><th valign="top" align="left">Peak F value</th><th valign="top" align="left">Cluster-level PFWE</th></tr></thead><tbody><tr><td valign="top" align="left">Thalamus</td><td valign="top" align="left">Right</td><td valign="top" align="left">102</td><td valign="top" align="left">6, −27, 12</td><td valign="top" align="left">14.49</td><td valign="top" align="left">0.003</td></tr><tr><td valign="top" align="left">Supplementary motor complex</td><td valign="top" align="left">Right</td><td valign="top" align="left">107</td><td valign="top" align="left">27, 15, 54</td><td valign="top" align="left">12.99</td><td valign="top" align="left">0.003</td></tr><tr><td valign="top" align="left">Supplementary motor complex</td><td valign="top" align="left">Left</td><td valign="top" align="left">103</td><td valign="top" align="left">−21, 12, 60</td><td valign="top" align="left">12.17</td><td valign="top" align="left">0.003</td></tr><tr><td valign="top" align="left">Cerebellum posterior lobe</td><td valign="top" align="left">Right</td><td valign="top" align="left">92</td><td valign="top" align="left">21, −42, −51</td><td valign="top" align="left">12.74</td><td valign="top" align="left">0.006</td></tr></tbody></table></div>ALFF, amplitude of low-frequency fluctuations; rsFC, resting-state functional connectivity; MNI, Montreal Neurological Institute.</transformed-table></extracted-table></extracted-tables-set>